Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases

Journal of Molecular Evolution

Volumn 72, Issue 2, 2011, Pages 160-168

  Yuasa, Hajime J ^b   Ball, Helen J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

Comparative biochemistry; Enzymatic parameters; Fungi; Indoleamine 2,3 dioxygenase; Molecular evolution; Tryptophan metabolism

Indexed keywords

FUNGAL PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; RECOMBINANT PROTEIN; TRYPTOPHAN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; ASPERGILLUS ORYZAE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; KINETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOUSE; PHYLOGENY; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; STATISTICAL MODEL;

AMINO ACID SEQUENCE; ANIMALS; ASPERGILLUS ORYZAE; CLONING, MOLECULAR; EVOLUTION, MOLECULAR; FUNGAL PROTEINS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KINETICS; LIKELIHOOD FUNCTIONS; MICE; PHYLOGENY; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; TRYPTOPHAN;

ASPERGILLUS ORYZAE; FUNGI; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 79953328952     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-010-9412-5     Document Type: Article

References (34)

1. Austin CJD, Astelbauer F, Kosim-Satyaputra P, Ball HJ, Willows RD, Jamie JF, Hunt NH (2009) Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. Amino Acids 36:99-106
2. Austin CJD, Mailu BM, Maghzal GJ, Sanchez-Perez A, Rahlfs S, Zocher K, Yuasa HJ, Arthur JW, Becker K, Stocker R, Hunt NH, Ball HJ (2010) Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids 39:565-1578
3. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJD, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH (2007) Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396:203-213 (Pubitemid 46818792)
4. Ball HJ, Yuasa HJ, Austin CJD, Weiser S, Hunt NH (2009) Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 41:467-471
5. Batabyal D, Yeh S (2007) Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase. J Am Chem Soc 129:15690-15701
6. Berbee ML, Taylor JW (2000) Systematics and evolution. In: McLaughlin DJ, McLaughlin E (eds) The mycota, vol VIIB. Springer-Verlag, New York, pp 229-246
7. Bozza S, Fallarino F, Pitzurra L, Zelante T, Montagnoli C, Bellocchio S, Mosci P, Vacca C, Puccetti P, Romani L (2005) A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 174:2910-2918 (Pubitemid 40279709)
8. Chai LY, van de Veerdonk F, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, Lagrou K, Vonk AG, Maertens J, Joosten LA, Kullberg BJ, Netea MG (2010) Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 130:46-54
9. Chauhan N, Thackray SJ, Rafice SA, Eaton G, Lee M, Efimov I, Basran J, Jenkins PR, Mowat CG, Chapman SK, Raven EL (2009) Reassessment of the reaction mechanism in the heme dioxygenases. J Am Chem Soc 131:4186-4187
10. Forouhar F, Anderson JL, Mowat CG, Vorobiev SM, Hussain A, Abashidze M, Bruckmann C, Thackray SJ, Seetharaman J, Tucker T, Xiao R, Ma LC, Zhao L, Acton TB, Montelione GT, Chapman SK, Tong L (2007) Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA 104:473-478 (Pubitemid 46123050)
11. Heckman DS, Geiser DM, Eidell BR, Stauffer RL, Kardos NL, Hedges SB (2001) Molecular evidence for the early colonization of land by fungi and plants. Science 293:1129-1133 (Pubitemid 32758092)
12. Hou DY, Muller AJ, Sharma MD, DuHadaway J, Banerjee T, Johnson M, Mellor AL, Prendergast GC, Munn DH (2007) Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res 67:792-801 (Pubitemid 46192220)
13. Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2:8
14. Kujundzić RN, Lowenthal JW (2008) The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma. Immunol Lett 115:153-159
15. Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P (2009a) Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9:445-452
16. Löb S, Königsrainer A, Zieker D, Brücher BL, Rammensee HG, Opelz G, Terness P (2009b) IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother 58:153-157
17. Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyltryptophan. Cancer Res 67:7082-7087 (Pubitemid 47206533)
18. Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC (2005) Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med 11:312-319 (Pubitemid 40460560)
19. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193 (Pubitemid 28406294)
20. Munn DH, Sharma MD, Hou F, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:289-290
21. Notredame C, Higgins DG, Heringa J (2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205-217
22. Panozzo C, Nawara M, Suski C, Kucharczyka R, Skoneczny M, Becam AM, Rytka J, Herbert CJ (2002) Aerobic and anaerobic NAD? metabolism in Saccharomyces cerevisiae. FEBS Lett 517:97-102 (Pubitemid 34327639)
23. Papadopoulou ND, Mewies M, McLean KJ, Seward HE, Svistunenko DA, Munro AW, Raven EL (2005) Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis. Biochemistry 44:14318-14328 (Pubitemid 41533056)
24. Ren S, Liu H, Licad E, Correia MA (1996) Expression of rat liver tryptophan 2,3-dioxygenase in Escherichia coli: structural and functional characterization of the purified enzyme. Arch Biochem Biophys 333:96-102 (Pubitemid 26276978)
25. Schmidt HA, von Haeseler A (2003) Maximum-likelihood analysis using TREE-PUZZLE. In: Baxevanis AD, Davison DB, Page RDM, Stormo G, Stein L (eds) Current protocols in bioinformatics. Wiley, New York, Unit 6.6
26. Searles LL, Voelker RA (1986) Molecular characterization of the Drosophila vermilion locus and its suppressible alleles. Proc Natl Acad Sci USA 83:404-408 (Pubitemid 16080021)
27. Suzuki T, Yokouchi K, Kawamichi H, Yamamoto Y, Uda K, Yuasa HJ (2003) Comparison of the sequences of Turbo and Sulculus indoleamine dioxygenase-like myoglobin genes. Gene 308:89-94 (Pubitemid 36597826)
28. Takikawa O (2005) Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. Biochem Biophys Res Commun 338:12-29
29. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-2522 (Pubitemid 21905800)
30. Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-1274 (Pubitemid 37279849)
31. Yuasa HJ, Suzuki T (2005) Do molluscs possess indoleamine 2,3-dioxygenase? Comp Biochem Physiol B 140:445-454
32. Yuasa HJ, Takubo M, Takahashi A, Hasegawa T, Noma H, Suzuki T (2007) Evolution of vertebrate indoleamine 2,3-dioxygenases. J Mol Evol 65:705-714
33. Yuasa HJ, Ball HJ, Ho YF, Austin CJD, Whittington CM, Belov K, Maghzal GJ, Jermiin LS, Hunt NH (2009) Characterization and evolution of vertebrate indoleamine 2,3-dioxygenases: IDOs from monotremes and marsupials. Comp Biochem Physiol B 153:137-144
34. Yuasa HJ, Ball HJ, Austin CJD, HuntNH(2010) 1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan. Comp Biochem Physiol B 157:10-15